Rx (Prescription Medicine)
USD $ 156.00
Cabzored 60mg Tablet 是一种主要用于抗癌的药物。其活性成分 Cabozantinib 是一种酪氨酸激酶抑制剂，可阻断参与癌细胞生长、增殖及血管生成的特定蛋白的活性，从而减缓或停止癌细胞的生长，并可降低癌症向其他部位的转移。此作用有助于延缓或阻止癌细胞的增长，并可减少癌症向其他部位的扩散。
Cabzored 60mg Tablet 适用于治疗某些类型的癌症，包括已接受系统治疗的转移性肾细胞癌（肾癌）和肝细胞癌（肝癌）患者。它也可用于对放射性碘治疗不敏感的转移性或局部进展性分化甲状腺癌。
Cabzored 60mg Tablet 的典型剂量由医疗专业人员根据具体的癌症类型和阶段、患者的个体反应及耐受性确定。通常口服，可与食物同服或空腹服用，每天同一时间服用。务必严格遵循医师 prescribed 的剂量和治疗周期。
常见不良反应可能包括腹泻、疲劳、恶心、呕吐、食欲下降、高血压、皮疹和口腔黏膜炎症。更严重的不良反应可能发生，因此如有任何疑虑请与医生讨论。Cabzored 60mg Tablet 应储存在室温，避免潮湿和热源，并置于儿童不可见的地方。
| Molecule | |
|---|---|
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type | |
| Brand Name |
其他品牌的 Cabozantinib 60 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
